Why Is Synaptogenix (SNPX) Stock Plummeting 70% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

With Synaptogenix’s clinical trial failure regarding its Alzheimer's drug candidate, SNPX stock tumbled on the broader implications.

The post Why Is Synaptogenix (SNPX) Stock Plummeting 70% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.